Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study.

Bertrand BaussartChiara VillaAnne JouinotMarie-Laure Raffin-SansonLuc FoubertLaure CazabatMichèle BernierFideline BonnetAnthony DohanJerome BertheratGuillaume AssiéStephan Gaillard

Published in: European journal of endocrinology (2021)

In well-selected microprolactinoma patients, pituitary surgery performed by an expert neurosurgical team is a valid first-line alternative treatment to dopamine agonists.

Keyphrases

minimally invasive
coronary artery bypass
end stage renal disease
ejection fraction
uric acid
newly diagnosed
prognostic factors
peritoneal dialysis
combination therapy
surgical site infection
growth hormone
acute coronary syndrome
patient reported outcomes
clinical practice